%0 Journal Article %T Usher syndrome IIIA: a review of the disorder and preclinical research advances in therapeutic approaches. %A Marouf A %A Johnson B %A Alagramam KN %A Marouf A %A Johnson B %A Alagramam KN %A Marouf A %A Johnson B %A Alagramam KN %J Hum Genet %V 141 %N 3 %D Apr 2022 %M 35320418 %F 5.881 %R 10.1007/s00439-022-02446-9 %X Usher syndrome (USH) is an autosomal recessive disorder characterized by sensorineural hearing loss, progressive pigmentary retinopathy, and vestibular dysfunction. The degree and onset of hearing loss vary among subtypes I, II, and III, while blindness often occurs in the second to fourth decades of life. Usher type III (USH3), characterized by postlingual progressive sensorineural hearing loss, varying levels of vestibular dysfunction, and varying degrees of visual impairment, typically manifests in the first to second decades of life. While USH3 is rare, it is highly prevalent in certain populations. RP61, USH3, and USH3A symbolize the same disorder, with the latter symbol used more frequently in recent literature. This review focuses on the clinical features, epidemiology, molecular genetics, treatment, and research advances for sensory deficits in USH3A.